Effect of Preoperative Oral Carbohydrate Administration in Thoracic Surgery Patients
oralcarbohydra
1 other identifier
interventional
94
1 country
1
Brief Summary
Preoperative carbohydrate loading has been shown to reduce pre-operative discomfort and postoperative nausea and vomiting. There is no need for prolonged preoperative fasting of the patients, but the traditional approach still continues especially in thoracic surgery patients. For this purpose, we aimed to evaluate the effect of preoperative carbohydrate loading on postoperative morbidity in the patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2018
CompletedFirst Submitted
Initial submission to the registry
August 8, 2021
CompletedFirst Posted
Study publicly available on registry
August 13, 2021
CompletedAugust 13, 2021
August 1, 2021
1.3 years
August 8, 2021
August 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mobilization time
postoperative mobilization
1 hour
Study Arms (2)
oral carbohydrate
ACTIVE COMPARATORthe patients drunk oral carbohydrate two hours ago preoperatively
no oral carbohydrate
NO INTERVENTIONthe patients did not drink oral carbohydrate preoperatively
Interventions
100 ml oral carbohydrate two hours ago preoperatively
Eligibility Criteria
You may qualify if:
- Stage I-Stage II all operable NSCLC patients -
You may not qualify if:
- Patients with diabetes mellitus, a history of delayed gastric emptying, severe hepatic or renal failure, or any endocrine disorder that might influence the metabolic parameters were excluded, as were patients requiring urgent or emergent surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
health Science University, Sureyyapa Training and Research Hospital
Istanbul, 34857, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- SureyyapasaM
Study Record Dates
First Submitted
August 8, 2021
First Posted
August 13, 2021
Study Start
January 1, 2017
Primary Completion
April 30, 2018
Study Completion
April 30, 2018
Last Updated
August 13, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share